• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INTEGRA - PRINCETON DURASEAL DURAL SEALANT SYSTEM 5ML US BOX OF 5; DURASEAL CRANIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INTEGRA - PRINCETON DURASEAL DURAL SEALANT SYSTEM 5ML US BOX OF 5; DURASEAL CRANIAL Back to Search Results
Catalog Number 202050
Device Problem Coagulation in Device or Device Ingredient (1096)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/04/2022
Event Type  malfunction  
Manufacturer Narrative
The duraseal dural sealant system (202050) was returned for evaluation: device history record: dhr review was performed (including raw material lab testing and release), at the time of manufacturing, records from each manufacturing lot are thoroughly reviewed to ensure that products are released meeting all quality release specifications.Failure analysis - integra has performed a thorough review of the reported incident.The sample returned had the following components: 1 polybag with ifu, opened tray, lid and pouch, with components of a polymer kit.The polymer kit returned had the following: 1 activated peg vial , 2 syringes with their caps, 1 y-connector with no usage signs, 3 spray tips with no usage signs, 1 plunger cap and 1 syringe holder.The borate syringe was found unused, with full 2.5ml.The phosphate syringe was found engaged to the bioset spike without any solution, or any traces of blue peg inside of the syringe.The peg vial had the bioset spike fully depressed, no redline visible, with pieces of dry blue clumps of peg inside of the vial.The bioset spike was not damaged.It is not possible to determine at which point the peg clumped or melted (during transportation to the customer, or during transportation back to manufacturing site for investigation), however since the bioset spike was activated, this could explain why the returned sample has peg that is clumped and blue (the peg inside the vial is hygroscopic, as such air and moisture make it clump/melt and turn blue).Water was placed in the phosphate syringe and it was engaged to the bioset spike to inject the water in the vial.The water was able to inject in the vial, then, the vial was mixed until most of the peg stuck in the walls was able to be removed.The water inside was easy to withdraw from vial to the syringe.The spike was removed and no physical damaged was observed on it.There were no leaks, all components looked acceptable per raw material specification.Root cause - the root cause is undetermined at this time, and the reported condition "jellified" was not confirmed in the complaint evaluation.A dhr review and trending were performed as part of the evaluation.Proper finished good testing was performed prior to release as indicated in the dhr.Per the fmea, potential causes of failure include: performance, adhesion barrier.The risk remains acceptable per the risk analysis.
 
Event Description
A facility reported that the diluent syringe of duraseal dural sealant system (202050) became jellied formation during a procedure described as "tumor dura." there was no patient injury and delay in surgery is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DURASEAL DURAL SEALANT SYSTEM 5ML US BOX OF 5
Type of Device
DURASEAL CRANIAL
Manufacturer (Section D)
INTEGRA - PRINCETON
1100 campus road
1100 campus road
princeton NJ
Manufacturer (Section G)
INTEGRA - PRINCETON
1100 campus road
none
princeton NJ
Manufacturer Contact
vivian nelson
1100 campus drive
princeton, NJ 
6099362319
MDR Report Key14493311
MDR Text Key292580012
Report Number3003418325-2022-00009
Device Sequence Number1
Product Code NQR
Combination Product (y/n)N
PMA/PMN Number
P040034
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,User Facility,Company Representative
Reporter Occupation Other
Type of Report Initial
Report Date 05/24/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number202050
Device Lot Number60267003
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/16/2022
Initial Date Manufacturer Received 05/05/2022
Initial Date FDA Received05/25/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/01/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
-
-